US approves 2nd gene therapy for blood cancer – The Hindu
The Hindu |
US approves 2nd gene therapy for blood cancer
The Hindu U.S. regulators have approved a second gene therapy for a blood cancer, a one-time, custom-made treatment for aggressive lymphoma in adults. The Food and Drug Administration (FDA) allowed sales of the treatment from Kite Pharma. It uses the same … FDA approves 2nd gene therapy targeting non-Hodgkin lymphomas FDA approves gene therapy to treat cancer in white blood cells New gene therapy conquers blood cancer |
